National Health Investors Inc (NYSE:NHI) Expected to Post Earnings of $1.40 Per Share

Analysts expect that National Health Investors Inc (NYSE:NHI) will post earnings per share (EPS) of $1.40 for the current quarter, according to Zacks. Four analysts have provided estimates for National Health Investors’ earnings, with the highest EPS estimate coming in at $1.40 and the lowest estimate coming in at $1.39. National Health Investors reported earnings of $1.39 per share during the same quarter last year, which suggests a positive year over year growth rate of 0.7%. The business is expected to report its next quarterly earnings report on Tuesday, November 5th.

According to Zacks, analysts expect that National Health Investors will report full-year earnings of $5.49 per share for the current financial year, with EPS estimates ranging from $5.48 to $5.50. For the next financial year, analysts expect that the company will post earnings of $5.75 per share, with EPS estimates ranging from $5.71 to $5.79. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that that provide coverage for National Health Investors.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Thursday, August 8th. The real estate investment trust reported $0.92 EPS for the quarter, missing the Zacks’ consensus estimate of $1.37 by ($0.45). The business had revenue of $78.10 million during the quarter, compared to analyst estimates of $77.64 million. National Health Investors had a net margin of 50.71% and a return on equity of 11.00%. The firm’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.38 EPS.

Separately, Zacks Investment Research lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating and five have issued a hold rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $79.60.

Shares of National Health Investors stock traded up $0.73 during mid-day trading on Friday, hitting $82.83. The stock had a trading volume of 146,100 shares, compared to its average volume of 153,777. The firm has a 50-day moving average of $79.83 and a two-hundred day moving average of $79.01. National Health Investors has a 12-month low of $70.54 and a 12-month high of $84.57. The company has a quick ratio of 14.99, a current ratio of 14.42 and a debt-to-equity ratio of 1.04. The firm has a market cap of $3.54 billion, a P/E ratio of 15.11, a price-to-earnings-growth ratio of 3.72 and a beta of 0.37.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Monday, September 30th will be issued a $1.05 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $4.20 dividend on an annualized basis and a dividend yield of 5.07%. National Health Investors’s payout ratio is 76.64%.

In other news, CIO Kevin Carlton Pascoe sold 900 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $82.46, for a total value of $74,214.00. Following the sale, the executive now directly owns 27,826 shares in the company, valued at approximately $2,294,531.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 5.11% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Lee Danner & Bass Inc. raised its position in National Health Investors by 0.6% during the second quarter. Lee Danner & Bass Inc. now owns 139,982 shares of the real estate investment trust’s stock valued at $10,923,000 after acquiring an additional 800 shares in the last quarter. Farmers National Bank bought a new stake in shares of National Health Investors during the 1st quarter worth $49,000. Fort Washington Investment Advisors Inc. OH lifted its position in shares of National Health Investors by 44.9% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 6,458 shares of the real estate investment trust’s stock worth $507,000 after buying an additional 2,000 shares during the last quarter. BlackRock Inc. lifted its position in shares of National Health Investors by 0.5% during the 1st quarter. BlackRock Inc. now owns 4,238,190 shares of the real estate investment trust’s stock worth $332,910,000 after buying an additional 21,764 shares during the last quarter. Finally, Raymond James & Associates lifted its position in shares of National Health Investors by 3.1% during the 1st quarter. Raymond James & Associates now owns 62,906 shares of the real estate investment trust’s stock worth $4,941,000 after buying an additional 1,916 shares during the last quarter. Institutional investors and hedge funds own 70.14% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Google Finance

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.